Skip to main content

This site is intended for U.S. residents only

Instructions for Use
Prescribing Information
Important Safety Information
Healthcare Professional Site

About
- About
- ALGS
- PFIC
MOA
Clinical Programs
- Clinical Programs
- ALGS
  ASSERT Trial Program
  Inclusion Criteria
- PFIC
  PEDFIC Trial Program
  PFIC Types
  Limitations of Use
Efficacy & Results
- Efficacy & Results
- ALGS
  Pruritus
  Sleep
  sBA
- PFIC
  Pruritus
  Sleep
  sBA
Safety
- Safety
- ALGS
- PFIC
Dosing
Resources
- Resources
- Practice Resources
- Practitioner Perspectives
- Patient Stories

About

ALGS ^{(Alagille Syndrome)}

PFIC^{(Progressive Familial Intrahepatic Cholestasis)}

Clinical Programs

ALGS ^{(Alagille Syndrome)}

ASSERT Trial Program Inclusion Criteria

PFIC^{(Progressive Familial Intrahepatic Cholestasis)}

PEDFIC Trial Program PFIC Types Understanding Limitation of Use

Efficacy & Results

ALGS ^{(Alagille Syndrome)}

Pruritus Sleep sBA

PFIC ^{(Progressive Familial Intrahepatic Cholestasis)}

Pruritus Sleep sBA

Safety

ALGS ^{(Alagille Syndrome)}

PFIC^{(Progressive Familial Intrahepatic Cholestasis)}

Resources

Practitioner Perspectives Patient Stories Patient Support & Access

This site is intended for U.S. residents only

About
- ALGS
- PFIC
MOA
Clinical Programs
- ALGS
  ASSERT Trial Program
  Inclusion Criteria
- PFIC
  PEDFIC Trial Program
  PFIC Types
  Understanding Limitations of Use
Efficacy & Results
- ALGS
  Pruritus
  Sleep
  sBA
- PFIC
  Pruritus
  Sleep
  sBA
Safety
- ALGS
- PFIC
Dosing
Resources

Instructions for Use
Prescribing Information
Important Safety Information
Healthcare Professional Site

Thank you.

You have successfully unsubscribed from any further BylvayHCP.com or Albireo emails.

This website is intended for U.S. Healthcare Professionals only

I certify that I am a healthcare professional in the U.S.

About Ipsen
IPSEN CARES
Privacy Policy
Terms of Use
Contact
Sitemap

BYLVAY is a registered trademark of Albireo Pharma, Inc., an Ipsen Company.

©2024 Albireo Pharma, Inc., an Ipsen Company. All rights reserved. BYL-US-000935 01/2024

BYLVAY is a registered trademark of Albireo Pharma,
inc., an Ipsen Company. ©2024 Albireo Pharma, Inc., an
Ipsen Company. All rights reserved. BYL-US-000935
01/2024

You are now leaving BylvayHCP.com

The website you are linking to is neither owned nor controlled by Albireo. Albireo is not responsible for the content or services on that site. Albireo makes no representation as to the accuracy of the information contained on third-party websites. You should review the applicable terms and policies, including privacy and data-gathering policies, of any website to which you navigate.